Kala Pharmaceuticals completes $22.5 million Series B financing

Kala Pharmaceuticals completed a $22.5 million Series B financing, according to a press release. The funding was led by Ysios Capital and also included Crown Venture Fund, Lux Capital, Polaris Partners and Third Rock Ventures.

Full Story →